Big bottlenecks in cardiovascular tissue engineering
- PMID: 30480100
- PMCID: PMC6249300
- DOI: 10.1038/s42003-018-0202-8
Big bottlenecks in cardiovascular tissue engineering
Abstract
Although tissue engineering using human-induced pluripotent stem cells is a promising approach for treatment of cardiovascular diseases, some limiting factors include the survival, electrical integration, maturity, scalability, and immune response of three-dimensional (3D) engineered tissues. Here we discuss these important roadblocks facing the tissue engineering field and suggest potential approaches to overcome these challenges.
Conflict of interest statement
J.C.W. has financial interest in Khoris Biosciences. All the remaining authors declare no competing interests.
Figures
Similar articles
-
Tissue Engineering Techniques for Induced Pluripotent Stem Cell Derived Three-Dimensional Cardiac Constructs.Tissue Eng Part B Rev. 2022 Aug;28(4):891-911. doi: 10.1089/ten.TEB.2021.0088. Epub 2021 Nov 23. Tissue Eng Part B Rev. 2022. PMID: 34476988 Free PMC article. Review.
-
Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies.Adv Drug Deliv Rev. 2016 Jan 15;96:234-244. doi: 10.1016/j.addr.2015.09.010. Epub 2015 Sep 30. Adv Drug Deliv Rev. 2016. PMID: 26428619 Free PMC article. Review.
-
Construction of 3D in vitro models by bioprinting human pluripotent stem cells: Challenges and opportunities.Brain Res. 2019 Nov 15;1723:146393. doi: 10.1016/j.brainres.2019.146393. Epub 2019 Aug 16. Brain Res. 2019. PMID: 31425681 Review.
-
Advances in three-dimensional bioprinted stem cell-based tissue engineering for cardiovascular regeneration.J Mol Cell Cardiol. 2022 Aug;169:13-27. doi: 10.1016/j.yjmcc.2022.04.017. Epub 2022 May 12. J Mol Cell Cardiol. 2022. PMID: 35569213 Free PMC article. Review.
-
Reconstructing the heart using iPSCs: Engineering strategies and applications.J Mol Cell Cardiol. 2021 Aug;157:56-65. doi: 10.1016/j.yjmcc.2021.04.006. Epub 2021 Apr 22. J Mol Cell Cardiol. 2021. PMID: 33895197 Free PMC article. Review.
Cited by
-
Engineering Cardiovascular Tissue Chips for Disease Modeling and Drug Screening Applications.Front Bioeng Biotechnol. 2021 Apr 20;9:673212. doi: 10.3389/fbioe.2021.673212. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 33959600 Free PMC article. Review.
-
Current challenges in three-dimensional bioprinting heart tissues for cardiac surgery.Eur J Cardiothorac Surg. 2020 Sep 1;58(3):500-510. doi: 10.1093/ejcts/ezaa093. Eur J Cardiothorac Surg. 2020. PMID: 32391914 Free PMC article. Review.
-
Cardiac muscle patches containing four types of cardiac cells derived from human pluripotent stem cells improve recovery from cardiac injury in mice.Cardiovasc Res. 2023 May 2;119(4):1062-1076. doi: 10.1093/cvr/cvad004. Cardiovasc Res. 2023. PMID: 36647784 Free PMC article.
-
Modelling the interaction between stem cells derived cardiomyocytes patches and host myocardium to aid non-arrhythmic engineered heart tissue design.PLoS Comput Biol. 2022 Apr 1;18(4):e1010030. doi: 10.1371/journal.pcbi.1010030. eCollection 2022 Apr. PLoS Comput Biol. 2022. PMID: 35363778 Free PMC article.
-
Challenges and opportunities for the next generation of cardiovascular tissue engineering.Nat Methods. 2022 Sep;19(9):1064-1071. doi: 10.1038/s41592-022-01591-3. Epub 2022 Sep 5. Nat Methods. 2022. PMID: 36064773 Free PMC article. Review.